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Abstract
Background: The E1 protein of Hepatitis C Virus (HCV) can be dissected into two distinct
hydrophobic regions: a central domain containing an hypothetical fusion peptide (FP), and a C-
terminal domain (CT) comprising two segments, a pre-anchor and a trans-membrane (TM) region.
In the currently accepted model of the viral fusion process, the FP and the TM regions are
considered to be closely juxtaposed in the post-fusion structure and their physical interaction
cannot be excluded. In the present study, we took advantage of the natural sequence variability
present among HCV strains to test, by purely sequence-based computational tools, the hypothesis
that in this virus the fusion process involves the physical interaction of the FP and CT regions of E1.
Results: Two computational approaches were applied. The first one is based on the co-evolution
paradigm of interacting peptides and consequently on the correlation between the distance
matrices generated by the sequence alignment method applied to FP and CT primary structures,
respectively. In spite of the relatively low random genetic drift between genotypes, co-evolution
analysis of sequences from five HCV genotypes revealed a greater correlation between the FP and
CT domains than respect to a control HCV sequence from Core protein, so giving a clear, albeit
still inconclusive, support to the physical interaction hypothesis.
The second approach relies upon a non-linear signal analysis method widely used in protein science
called Recurrence Quantification Analysis (RQA). This method allows for a direct comparison of
domains for the presence of common hydrophobicity patterns, on which the physical interaction
is based upon. RQA greatly strengthened the reliability of the hypothesis by the scoring of a lot of
cross-recurrences between FP and CT peptides hydrophobicity patterning largely outnumbering
chance expectations and pointing to putative interaction sites. Intriguingly, mutations in the CT
region of E1, reducing the fusion process in vitro, strongly reduced the amount of cross-recurrence
further supporting interaction between this region and FP.
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Conclusion: Our results support a fusion model for HCV in which the FP and the C-terminal
region of E1 are juxtaposed and interact in the post-fusion structure. These findings have general
implications for viruses, as any visualization of the post-fusion FP-TM complex has been precluded
by the impossibility to obtain crystallised viral fusion proteins containing the trans-membrane
region. This limitation gives to sequence based modelling efforts a crucial role in the sketching of a
molecular interpretation of the fusion process. Moreover, our data also have a more general
relevance for cell biology as the mechanism of intracellular fusion showed remarkable similarities
with viral fusion
Background
Hepatitis C virus (HCV) is a positive-strand RNA virus that
belongs to the family of Flaviviridae [1]. The genome of
HCV encodes for two envelope glycoproteins designated
as E1 and E2 respectively. E1 and E2 are classified as type
I transmembrane (TM) glycoproteins, and show a N-ter-
minal ectodomain and a C-terminal TM domain. The El
and E2 proteins interact to form a noncovalent het-
erodimer which is present at the surface of the viral parti-
cle and mediates the entry of HCV into host cell [2]. After
viral binding to a cellular receptor(s) and endocytosis, the
E1E2 complex is thought to induce fusion between the
viral envelope and a membrane of an internal compart-
ment of host cell [3,4]. However, the definite identifica-
tion of the fusion protein is still lacking.
A common property of the fusion proteins of other mem-
bers of the Flaviviridae family, such as tick-borne encepha-
litis virus (TBE) and dengue virus, is their presence at the
viral surface as a dimer that, when activated by an appro-
priate trigger (acidic pH in the endosome), undergoes a
transition to a trimeric state. These structural rearrange-
ments expose a hydrophobic domain, called fusion pep-
tide or fusion loop, allowing its insertion into the host cell
membrane [5].
Fusion proteins have been divided into class I (Retrovi-
ruses, Orthomyxoviruses) and class II (Flaviviruses,
Alphaviruses) proteins on the basis of their different struc-
ture. However, similarities in the post-fusion conforma-
tion suggest that the corresponding fusion processes are
mechanistically related [5-8]. In the pre-fusion conforma-
tion the TM and FP segments are at the opposite ends of
the fusion protein: the TM is anchored to the viral mem-
brane while the FP is inserted into the host cell mem-
brane. In the following steps, the protein folds back on
itself directing the C-terminal TM anchor towards the
fusion peptide along with their associated membranes.
These structural changes lead to a final highly stable rod-
like conformation in which the TM and the FP domains
are at the same end of the molecule and are closely juxta-
posed in the same fused membrane [5]. This transition
suggests the physical interaction between the TM anchor
region and the fusion peptide as one of the key events that
force the cellular and the viral membranes into close
apposition to trigger a complete fusion.
The similarities with other Flaviviruses suggest that HCV
may harbour a class II fusion protein, however its identi-
fication is still controversial. Recent data suggest that both
E1 and E2 may participate in the membrane fusion by a
complex mechanism which involves multiple hydropho-
bic regions of these glycoproteins [4,9]. Although the spe-
cific function of each region is still not defined, it has been
proposed by several groups that the E1 protein could play
an active role in the fusion process as it contains the puta-
tive fusion peptide of HCV [9-14].
The analysis of the secondary structure of E1 reveals that it
contains two long hydrophobic regions which show
membrane-associating properties [10,15] and are strongly
conserved among all HCV isolates [16]. One region is
localized in a central position (aa 259–298) and the other
(aa 331–383) at the C-terminal end (reported as FP and
CT, respectively, in Fig. 1). The central segment has been
suggested to contain the putative fusion peptide of HCV
[9-14]. The hydrophobic CT region contains an amphip-
athic pre-anchor domain (aa 331–347) [17] followed by
Schematic diagram of the E1 regions analyzed in this study Figure 1
Schematic diagram of the E1 regions analyzed in this 
study. The Kyte & Doolittle (continuous line) and Goldman 
(dashed line) hydrophobicity plots of the E1 protein is shown 
at the top. The studied E1 fragments are indicated as shaded 
boxes. The trans-membrane (TM) domain is also shown. Key 
amino acid positions are indicated.
FP CT IT
191 298 259 331 383 352
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the TM region (aa 353–383) [18]. Recently, it was shown
that a fragment of E1 (aa 317–339), which includes part
of the hydrophobic region of pre-anchor, is capable of
destabilizing model membranes [14,19]. Interestingly,
HCV pseudoparticles (HCVpp) containing mutations in
each of the hydrophobic domains of E1 showed reduced
fusion property [9,11,20].
In the present paper, we used a computational approach
to evaluate the possible interaction between the hydro-
phobic regions of E1, FP and CT (Fig. 1), as a potential key
step in the mechanism of membrane fusion. To model
this interaction, we analysed a dataset containing
sequences from 5 HCV genotypes by means of two inde-
pendent computational approaches. The first one is a
sequence alignment method building upon the hypothe-
sis that two interacting sequences, given the need to satisfy
shared physical interaction constraints, display a much
greater degree of co-evolution (estimated in terms of cor-
relation of sequence variability among different strains)
than two non-interacting proteins. This paradigm was
demonstrated to be very effective in detection of interact-
ing peptides [21,22].
The second one was based upon Recurrence Quantifica-
tion Analysis (RQA) [23] as applied to the putatively
interacting sequences transformed into numerical series
by the coding of residues with their relative hydrophobic-
ity [24]. After this step, the amount of different size
patches of the two putative partners displaying a similar
hydrophobic patterning is scored so to derive some global
measures of hydrophobic patterning cross-correlation
between the two partners. This method is based upon the
large body of evidence indicating two mutually binding
regions tend to share the same hydrophobic patterning so
both minimizing the energy of the complex (thermody-
namic constraint) and maximizing the amount of time
the two partners stay aside, so increasing the interaction
probability (kinetic constraint) [25,26]. RQA in turn was
demonstrated extremely efficient to predict protein-pro-
tein interaction in different settings [24,27-30].
Results
Analysis of E1 domains by sequence alignment/co-
evolution method
To evaluate the probability of the hypothesized interac-
tion between the two hydrophobic regions of E1 protein
(Fig. 1, see FP and CT), we assembled a sequence dataset
by retrieving from public database twelve E1 protein
sequences belonging to 5 different HCV genotypes and, in
the case of genotype 1, two subtypes (1a, 1b, 2a, 3a, 4a,
5a) (see Methods for accession numbers). A fragment
from the Core protein sequence (aa 39–74), simply called
"Core" for the sake of brevity in the present paper, was
selected from a conserved region of the Core protein
showing high content of charged amino acids (R and K);
this region appears a good control for our analysis,
because it may represent a HCV-RNA binding site and,
thus, it is unlikely to be an interacting site for E1 in the
viral particle [31].
The dataset was analyzed by the co-evolution method
based on the comparison between the inter-strains
sequence superposition computed on FP and CT peptides,
respectively. This analysis is based on the observation that
two interacting proteins have a much more "constrained"
evolutionary space than a pair of non interacting proteins
and consequently much less room for random genetic
drift [21,22]; this ends up into a much higher resemblance
of the between strains differences measured over interact-
ing proteins than over random protein pairs. On this
basis, we compared the correlation between the distance
matrices relative to HCV genotypes for FP and CT
domains (autologous comparison, i.e. comparison inside
the same E1 protein) with the correlation of the distance
matrices computed over both FP and CT peptides with the
distance matrices computed over a fragment of the HCV
Core protein (heterologous comparison, i.e. comparison
with an independent protein). It is important to stress that
we are not comparing the relative amount of sequence
homology between the different peptides, but simply if
the "between genotypes" similarities for the same peptide
remain more invariant in FP-CT comparisons than in FP-
Core and CT-Core comparisons.
Analysis was carried out by applying ClustalW to all the
possible genotype pairs separately for the different pep-
tides so to generate three distinct "between genotypes"
distance matrices, one for each peptide (FP, CT and Core).
Then the three distance matrices were each other corre-
lated giving rise to the following mutual correlations: FP/
CT = 0.62, FP/Core = 0.43 and CT/Core = 0.44. These val-
ues are indicative of a greater correlation between FP and
CT, according to their supposed interaction. However, the
evidences are still preliminary being the cross-correlation
between interacting pairs only marginally different from
the non-interacting pairs. This probably comes from the
relatively low random genetic drift between HCV geno-
types that is a feature frequently observed in viruses [27].
This low random genetic drift generates an artificially high
correlation even for non interacting pairs.
Analysis of E1 domains by RQA technique
To overcome the limitations of the sequence homology
approach, we then applied the Recurrence Quantification
Analysis (RQA) approach [27]. This method investigates
the presence of cross-correlations between different
hydrophobicity patches of the analysed peptides, so to
highlight the possible presence of hydrophobic zippering
interaction motifs [30,32].BMC Structural Biology 2009, 9:48 http://www.biomedcentral.com/1472-6807/9/48
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In order to have a quantitative appreciation of the cross
recurrences we used two numerical descriptors of the
amount of cross recurrence: the percentage of recurrent
pairs, called REC, and the percentage of "deterministic
recurrences", called DET [23,24] (see Methods for details).
As shown in Fig. 2, the cross-recurrence plot for FP and CT
peptides of genotype 1b revealed that the two peptides
display a lot of cross-recurrences (patches with very simi-
lar hydrophobicity patterns) that could mark hydropho-
bic regions of mutual interaction; moreover these regions
appear in ordered columns so stressing the plausibility of
spots of mutual interaction between peptides. The differ-
ent length of FP and CT peptides (30 and 53 residues
respectively) constrained us to work on contiguous
(shifted by one residue at time) versions of the CT peptide
so to match the FP peptide with subsequent equal length
(30 residues) peptides. These subsequent windows give
rise to almost identical cross-recurrence values for a given
genotype, so we can safely substitute the average cross-
recurrence parameters for each comparison as specific
genotype cross-recurrence values (REC and DET).
In addition to the FP and CT comparison, we included as
control sequence another fragment of the E1 protein (aa
299–330), called IT in the present paper (Fig. 1). This frag-
ment is highly conserved in HCV [31] and contains an
epitope for human neutralizing monoclonal antibodies,
suggesting its location on viral surface [33]. For this rea-
son, it is not expected to participate directly to the physical
interaction between the FP and CT portions into the
membrane but nevertheless is expected to display a
greater resemblance with both FP and CT with respect to
Core for its pertaining to the same integrated system (E1
protein).
As a matter of fact, being IT a fragment of E1 protein as FP
and CT, it cannot be absolutely excluded that even the IT
sequence follows the co-evolution drive of FP and CT,
thus, we included a further control fragment from a com-
pletely different HCV protein, i.e. Core protein. The Core
fragment, previously described; was shown to interact
with viral RNA and, thus, supposed to be located inside
the virion capsid, in a completely different location with
respect to both FP and CT and thus it is not expected to co-
evolve with these latter fragments of E1.
The strategy to include the described controls (IT and
Core) allowed to check two effects: (a) the inside-protein
and (b) the autologous/heterologous relations. In fact, the
need of having a global optimised protein structure could
insert some cross-correlation among amino acid patches
of the same protein, even if they do not physically inter-
act. If the hypothesized model is correct we thus expect a
descending order cross correlation such as: CT-FP > CT-IT
> CT-Core.
In Fig. 3A, the different couples of peptides are sampled in
the REC/DET plane with autologous (FP/IT, FP/CT, IT/
CT) and heterologous pairs (FP/Core, CT/Core, IT/Core)
reported as black and white dots, respectively. The differ-
ence between the two conditions is striking: the amount
of cross correlation indicated that autologous pairs were
more correlated than heterologous (FP/IT, FP/CT, IT/CT >
FP/Core, CT/Core, IT/Core).
In order to get a statistical significance appreciation of this
difference we performed an analysis of variance on both
REC and DET descriptors taking into consideration both
the autologous/heterologous difference and the eventual
differences between genotypes (some genotypes having a
greater cross-correlation than others). To obtain a more
reliable and comprehensive score of the entity of cross-
correlation between different peptides we took advantage
of the correlation existing between REC and DET (Pearson
r = 0.53, p < 0.001). The existence of such a correlation
allowed to compute a first principal component of the
REC/DET plane positively correlated with REC and DET (r
= 0.87 with both REC and DET) and explaining 76% of
the total variability of the bi-dimensional REC-DET space
[see Additional file 1]. This component (Factor 1) can be
considered as a cumulative score collecting the common
portion of variation of the two REC and DET indices, thus
allowing for a more robust estimate of the actual cross cor-
relation of the different couples as for hydrophobicity pat-
terning reminiscent of the physical interaction between
An example of cross-recurrence plot of the FP-CT compari- son (genotype 1b) Figure 2
An example of cross-recurrence plot of the FP-CT 
comparison (genotype 1b). Each black dot represents a 
cross-recurrence, i.e. very similar hydrophobicity between 
the compared amino acid residues from FP and CT peptides.
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the corresponding peptides. The general dataset after com-
putation of the first principal component is shown in a
supplementary file [see Additional file 2].
In order to get the statistical significance of the autolo-
gous/heterologous comparison an Analysis of Variance
was carried out. The dependent variables were REC, DET
and Factor1 scores, and the independent sources of varia-
tion were the type of relation (autologous/heterologous)
and the genotype. In this way, together with the autolo-
gous/heterologous effect, we could check if a significant
"among-genotypes" difference was present. Results of this
analysis are reported in a supplementary file [see Addi-
tional file 3].
All the three descriptors were highly statistically signifi-
cant in the autologous/heterologous comparison, so
pointing to a neat "protein effect" in maintaining a gen-
eral shape of the protein. Factor1 was demonstrated to be
the most significant index (Rsquare = 0.74): this was
expected, as such a descriptor retains only the correlated
information of both REC and DET. REC was more effi-
cient than DET in discriminating the two classes, while no
significant genotype effect was singled out, indicating the
observed effect is common to all the genotypes and thus
indirectly indicating, as expected, the same interaction
occurs in all genotypes. If we consider a given protein as a
global ensemble with non-local rules shaping its confor-
mational space, this is a very important result. In some
sense, it is like the entire sequence presents the need of a
'self-interaction' between different portion of the mole-
cule driven by their mutual similarity [26,34]. We can
think the FP-IT-CT system as shaped, in terms of hydro-
phobicity patterning, by the need of carrying out a physi-
cal interaction. This need is clearly not present between
the Core fragment and the FP-IT-CT peptides, as shown by
a clear decrease in hydrophobic patterning correlation of
the heterologous couples. The descriptive statistics of
these indices is reported in Table 1.
If we focus only on the comparison among the autologous
pairs of peptides (Fig. 3B), the FP/CT couples (black dots)
seem to occupy (with one only exception) the most
extreme right portion of the graph, so indicating a possi-
ble preferential FP-CT attachment pairs. To give a statisti-
cal basis to this observation a Student's t-test was
performed (Table 2). All the three descriptors showed
highest average scores in FP/CT pairs with respect to
"other" couples, REC, DET and Factor1 all reached the sta-
tistical significance with an expected higher sensitivity for
Factor1 (that by construction is filtered out of noisy infor-
mation) (p < 0.003 and p < 0.04 for REC and DET respec-
tively and p < 0.0001 for Factor1). Thus, we can safely
state that the amount of cross recurrence of the FP/CT cou-
ples is significantly higher with respect to FP/IT and CT/IT,
so pointing to the existence of a some sort of FP/CT inter-
action. This result is the proof of the FP-CT > (CT-IT and
FP-IT) > (CT-Core and FP-Core) order of cross-correlation
we hypothesized in our model.
RQA analysis of FP-CT interaction as compared with 
NS4B-CT and E1TM-E2TM
In order to go in depth into the proof of the suggested
model, we evaluated the possibility that the evidence of a
DET and REC values from (A) autologous and heterologous  couples and from (B) FP-CT and other autologous couples Figure 3
DET and REC values from (A) autologous and heter-
ologous couples and from (B) FP-CT and other autol-
ogous couples. (A) Autologous pairs (FP/IT, FP/CT, IT/CT) 
(black dots) are more correlated than heterologous ones 
(FP/Core, CT/Core, IT/Core) (white dots). (B) Differently 
from other autologous couples (white dots), FP/CT couples 
(black dots) seem to occupy (with one only exception) the 
most extreme right portion of the graph, so indicating a pos-
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strongest interaction of the FP-CT pair with respect to
both CT-Core and FP-Core ones could be driven by the
fact we are correlating two membrane peptides in the FP-
CT case. In fact, membrane location of a peptide imposes
a deterministic structuring to hydrophobicity patterning
that could be at the basis of the observed FP-CT cross
recurrence structure.
In order to operate a more stringent control of the FP-CT
interaction, the amino-terminal fragment (aa 1712–
1737) from the NS4B protein of HCV was used as further
negative control for RQA. Indeed, this fragment was pre-
viously reported to interact with membranes [35] and,
being NS4B a non-structural protein, was not expected to
interact with the FP-CT system. The NS4B fragment will be
simply named "NS4B" further in the text.
The graphical comparisons in terms of determinism
(DET) of the FP-CT with both NS4B-CT (upper panel) and
Core-CT (lower panel) negative control pairings are
reported in supplementary file [see Additional file 4]. In
both cases FP-CT couples show a greater DET than the
negative controls (with the only exception of genotype 1b
that in any case is very near to the identity line) so point-
ing to the relevance of FP-CT interaction not merely deter-
mined by "membrane location".
To obtain a more clear assessment of the proposed inter-
action model, we included in the analysis a positive con-
trol. The trans-membrane C-terminal end (aa 717–745)
of E2 protein was experimentally demonstrated to have
physical interaction with the trans-membrane C-terminal
end (aa 352–383) of E1 [20]. Thus, we subjected these
fragments (named E2TM and E1TM, respectively) to RQA.
The behavior of E1TM-E2TM interaction is reported in a
supplementary file [see Additional file 5]. Here the signif-
icance of the results are still more clear: the positive con-
trol has consistently (and to a large extent) higher DET
values than both NS4B-CT (upper panel) and Core-CT
(lower panel) negative control pairs.
As last point we compared the FP-CT pair and the E1TM-
E2TM positive control in both the REC and DET spaces.
Although E1TM-E2TM interaction is consistently pre-
dicted as stronger in the DET plane (upper panel), this is
not the case in the REC plane (lower panel) where the two
interactions are more or less equivalent (sample points
disposed on both sides of the identity line) [see Addi-
tional file 6], further supporting the plausibility of our FP-
CT interaction model.
A very important additional proof of the proposed model
is the check of the "sequence order dependence" of the
obtained results, carried out by random scrambling the
amino acid order of the analyzed fragments. In the RQA
only DET parameter is affected by amino acid order (REC
parameter is only dependent on amino acid composi-
tion). Thus, if the observed interaction strength between
two peptides in terms of the DET descriptor remains
unchanged after random scrambling, this points to a
Table 1: Descriptive statistics of REC, DET and Factor1 indices in autologous and heterologous comparison
Autologous Heterologous
Variable N Mean Std Dev Min Max Mean Std Dev Min Max
REC 18 9.525 1.205 7.640 11.210 6.947 0.935 5.460 8.400
DET 18 16.876 6.434 8.100 31.310 8.330 3.342 4.050 15.120
Factor 1 18 0.804 0.696 -0.391 2.093 -0.804 0.452 -1.489 0.272
Table 2: Statistic description of REC, DET and Factor 1 indices in autologous comparisons.
Couple = other (FP/IT, CT/IT) Couple = FP/CT
Variable N Mean Std Dev Min N Mean Std Dev Min Max
REC 12 8.969 0.972 7.640 6 10.638 0.793 9.100 11.210
DET 12 16.374 7.258 8.100 6 17.880 4.801 12.920 24.520
Factor 1 12 0.572 0.728 -0.391 6 1.268 0.307 0.989 1.780
Statistical significance of observed REC, DET and Factor 1 values in the two groups by Student's t-test: REC p < 0.003; DET p < 0.04; Factor 1 p < 
0.0001.BMC Structural Biology 2009, 9:48 http://www.biomedcentral.com/1472-6807/9/48
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largely unspecific interaction between the two elements of
the pairs. In contrast, if the random shuffling of residue
order determines a marked drop of the DET variable, this
implies the native arrangement of the residues is crucially
important for driving the interaction. In a supplementary
file [see Additional file 7] it is shown that both E1TM-
E2TM and FP-CT interactions were destroyed by randomly
scrambling the residue order, with the "native" sequences
(position indicated by an arrow) having a greater DET
value than any scrambled sequence over a set of twenty
(positions indicated by black dots). As expected, NS4B-CT
interaction (negative control in RQA analysis) had a DET
value similar to the shuffled copies, so giving a further
confirmation to the FP-CT interaction.
Having obtained a multifaceted proof of the plausibility
of the FP-CT interaction, we carried out a finer analysis by
studying the effect of mutations on this interaction sys-
tem.
RQA analysis of E1 fusion mutants
In the last years, E1 mutations affecting viral fusion of
HCV 1a pseudotyped particles in vitro have been described
[9,11,20]. To evaluate whether hydrophobicity patterning
correlation could be influenced by such mutations, we
inserted them in the FP and CT domains of the same gen-
otype 1a, H77c isolate [GenBank:AF011751], and ana-
lysed the resulting sequences by RQA. Only the mutations
for which a frank decrease in biological effect was
observed were selected for the analysis (see Table 3).
Some simulated double mutations for which we had no
biological data were also computed in order to check the
relative sensitivity of cross-correlation parameters to FP
and CT patches.
If cross RQA is a sensitive indicator of the interaction
strength we expect a diminished cross-recurrence between
hydrophobicity patterning of the mutant peptides. It is
worth noting this is a much harder test than the one
described before. While the above analysis was based
upon the differences in cross-correlation between interact-
ing and non-interacting pairs, here we try and model the
different relative strength of interaction inside an interact-
ing pairs, i.e. we are dealing with interaction modulation
and not simply with its presence/absence. The observed
cross-recurrence between different FP/CT pairs was com-
puted by means of REC and DET descriptors together with
another typical RQA descriptor called laminarity (LAM)
that corresponds to the percentage of vertical (horizontal)
recurrent lines in the cross recurrence plot. The addition of
this descriptor to REC and DET was dictated by both the
need of modelling a very subtle effect (indeed the differ-
ent couples differ among them for only one residue out of
40) and by the fact that interaction is a strict order
dependent process in which the spatial disposition of
cross recurrences (as measured by both DET and LAM) is
much more crucial than their actual number (as measured
by REC). Table 4 reports the results obtained by the appli-
cation of cross recurrence to the different peptide couples.
As expected REC was strongly invariant among all the cou-
ples; in contrast both DET and LAM (strongly order
dependent parameters) show a drastic decrease in double
Table 3: Mutations in E1 protein affecting viral fusion in vitro
E1 domain aa substitution References
FP Y276F (Lavillette et al., 2007)
G282D (Lavillette et al., 2007)
Y276R (Drummer et al., 2007)
Y276A (Drummer et al., 2007)
F285A (Drummer et al., 2007)
CT V333A (Drummer et al., 2007)
L337A (Drummer et al., 2007)
M347A (Drummer et al., 2007)
L356W (Ciczora et al., 2007)
A360W (Ciczora et al., 2007)
Table 4: RQA analysis of different wild type (wt) or mutant FP 
and CT peptide couples
Sequence type FP CT REC DET LAM
wild type wt wt 13.00 26.32 24.81
FP mutant Y276R wt 12.90 26.50 25.00
FP mutant Y276A wt 13.50 27.50 23.80
FP mutant Y276F wt 13.10 27.60 26.60
FP mutant G282D wt 12.89 29.50 25.00
FP mutant F285A wt 13.10 27.15 25.20
CT mutant wt V333A 11.72 10.83 13.33
CT mutant wt L337A 11.52 10.17 10.17
CT mutant wt M347A 12.01 13.82 21.13
CT mutant wt L356W 11.72 16.67 21.67
CT mutant wt A360W 11.84 15.26 20.81
double mutant F285A V333A 12.60 17.82 12.40
double mutant Y276R L337A 11.40 11.97 10.26
double mutant Y276A M347A 12.70 17.70 20.00
*: the amino acid change of mutated versions is reportedBMC Structural Biology 2009, 9:48 http://www.biomedcentral.com/1472-6807/9/48
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mutants and in all the CT mutants. The decreases we
observed in both DET and LAM descriptors are approxi-
mately one half the wild type respective value. This is a
very remarkable result if we consider it is due to one resi-
due only substitution. No fusion mutant couple showed a
significantly increased cross correlation with respect to
wild type and mutation of the sole FP did not produce sig-
nificant changes in cross-correlation. The above results
suggest that mutations on CT patch are in general more
sensitive in terms of alteration of hydrophobicity pattern
(the double mutants have variation with respect to wild
type comparable to what observed with CT mutations
only). The lack of sensitivity of the method as for only FP
mutations probably points to a diminished strength of
hydrophobic patterning interaction constraints for FP
peptide with respect to CT.
All in all, the mutation analysis gives further strength to
the direct physical interaction hypothesis of FP and CT
peptides.
Discussion
In this report we have presented evidences indicating that
the C-terminal hydrophobic region of HCV E1 protein can
interact with the inner putative fusion peptide. This phys-
ical interaction is likely at the basis of the strong cross-cor-
relation between the hydrophobicity patterning of these
two domains and it may be part of a mechanism of pro-
tein refolding which leads to viral fusion to intracellular
membranes.
Our analysis was performed at a first level by the scoring
of an higher correlation in the "between strains" distance
matrices relative to the homologous (FP/CT) vs. the heter-
ologous (FP/Core, CT/Core) pairs. This gave us the idea
that some constraints to the random genetic drift were
present between homologous couples that were absent in
heterologous ones. The second level of analysis was
reached by the demonstration of a meaningful corre-
spondence between hydrophobicity patterning of homol-
ogous couples and that this correspondence was higher
for fusion peptide and C-terminal region pairs. This
allows us, given the crucial role of hydrophobicity for
both folding and protein protein interaction, to infer a
physical interaction between the two peptides. Moreover,
if variations of the entity of correlation between the two
peptide patterning are able to discriminate different
HCVpp fusion mutants, we can safely affirm that not only
the two peptides interact in some way but that their effec-
tive interaction can be quantitatively modeled on the
basis of their sequence. This may open the way, on the
long run, to rationally designed peptide based therapy
[25]. The fact FP mutations are not detectable by this
method has two-fold implications. First, hydrophobicity
is not the sole driving force of interaction process and
other elements like topology, steric hindrance, flexibility
are important actors of the play: the 'FP side' of interaction
could be more sensible to these other factors. Second, it is
conceivable that the described mutations interfere with
the first step of viral fusion. Indeed, they might block the
insertion of the fusion peptide into cell membranes with-
out affecting the following interaction with the C-terminal
anchor.
Although a fusion peptide has not been defined for E2,
three regions of this protein (aa 418–432, 597–620 and
675–699) [9,36] as well as its TM domain [20] have been
proposed to play a role in the fusion process by a still
unknown mechanism. The apparent lack of a fusion pep-
tide in E2 supports the hypothesis that this protein might
be indirectly involved in the fusion process by controlling
the conformational changes of E1E2 complex. Our data
seem to favour a view in which the fusion peptide and the
C-terminal anchor region of E1 play an active and direct
role in the fusion process of HCV, contributing to the first
step which leads to hemifusion of viral and cell mem-
branes, while other segments of E1 and E2 may contribute
to subsequent pore enlargement via major structural
changes. Recently it has been proposed an alternative
mechanism that involves the cooperation of the fusion
peptide of E1 with a putative stem region (aa 675–699) of
E2 [11]. This hypothesis is based on mutagenesis studies
which indicated that this last region is involved in E1E2
heterodimerization and in viral entry [36], two typical
functions of the Flavivirus stem domain. However, an
important function of the stem is also to bring the TM
anchor of the protein towards the fusion peptide of the
same molecule. This is an universal property of all viral
fusion proteins, common to both class I and class II mol-
ecules; thus, the cooperation of two different proteins (i.e.
E1 and E2) during this step of membrane fusion, though
possible, appears unlikely, as it would represent a novel
mechanism never described for any virus.
Viral fusion proteins of class II are elongated molecules
composed almost entirely of β strands and contain three
domains: the centrally located domain I; domain II which
is located at one side of domain I and contains the fusion
loop at its tip; and domain III which is connected at the
other side of domain I. Domain III is also connected by a
region called stem or pre-anchor, (50 aa) in E protein of
TBE, to the TM domain of the protein. Proteome compu-
tational analyses indicate that HCV E1 seems to be miss-
ing much of the stem region relative to the E protein of
TBE and represents the minimal class II fusion protein
structure required to mediate the virus-cell fusion [13]. As
for the stem region of E protein of TBE, the HCV E1 pre-
anchor sequence was also predicted to be an amphipathic
α helix with characteristics of a leucine zipper [13,17].
Moreover, mutagenesis of single positions in this regionBMC Structural Biology 2009, 9:48 http://www.biomedcentral.com/1472-6807/9/48
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affects viral fusion [11]. Finally, it was shown that two
synthetic peptides of E1, containing part of the hydropho-
bic region of pre-anchor, showed fusion activity on lipo-
some membrane (aa 317–339) as well as the ability to
destabilize model membranes (aa 309–340), a distinctive
feature of fragments involved in membrane fusion
[14,19].
Interestingly, in the class II fusion model the role of the
stem region would be to pull the TM anchor towards the
fusion loop and to tightly interact with sites located in
domain II in the final post-fusion conformation. It has
been proposed that the binding of the stem forces juxta-
position of the fusion peptide loop and the TM segment,
driving the opening of an initial fusion pore [6]. Most
importantly these functions may suggest strategies for
inhibiting Flavivirus entry. Indeed, peptides derived from
stem sequences could block completion of the conforma-
tional changes by interfering with stem binding sites. Our
analysis indicates that amino acids substitutions in the
pre-anchor region of E1 (V333A, L337A and M347A)
strongly reduced the amount of cross-recurrence suggest-
ing a possible interaction between this region and the
domain containing the fusion peptide. Interestingly, a
similar association of the trans-membrane domain with
the fusion peptide seems to represent a key event in the
fusion process of influenza virus [37]. If the interaction
between these two domains of E1 is required to complete
the fusion process, this step could be a potential target for
antiviral fusion inhibitors. An analogous strategy has been
used to inhibit HIV-1 entry, in this case peptides corre-
sponding to the C-terminal ectodomain of the gp41
fusion protein bind to the viral protein and block HIV-1
infection by preventing its conformational changes [38].
This approach was exemplified by the HIV-1 peptide T20/
Enfuvirtide, a licensed antiretroviral drug, which was
developed to interfere with gp41 protein refolding to the
final post-fusion structure [39,40].
Conclusion
Our findings suggest a physical interaction of the putative
fusion peptide and the C-terminal region of HCV E1 pro-
tein. This view is supported by (1) data from sequence
homology analysis, (2) high level of cross-recurrence
between the two domains (3) the sequence dependence of
the observed interaction strength and (4) the destroying
effect of single mutations in the C-terminal region on the
cross-recurrence. Consistent with their reported mem-
brane-active properties, interaction of these peptides
implicates they could be key players in the fusion process.
Though carried out on HCV sequences, our computa-
tional approach allowed to obtain data relevant for viral
fusion in general. In fact, a major limitation for studying
the structure of the post-fusion complex is that crystal-
lized proteins including the stem region and the TM
anchor could not be obtained [5-8]. Thus, the described
interaction between the fusion and trans-membrane pep-
tides, likely to occur in the post-fusion conformation, can-
not be directly visualized in the crystal structure. This
limitation gives to sequence based modeling efforts a cru-
cial role in the sketching of a molecular interpretation of
the fusion process, opening the way to rationally designed
peptide-based antiviral therapy [25].
Methods
Protein sequence dataset
Twelve HCV protein sequences spanning the core (1–190
aa) and E1 (191–383 aa) regions of HCV were randomly
selected from the HCV sequence database available at
http://hcv.lanl.gov/content/hcv-db/index. Two sequences
per each of the worldwide distributed 1a, 1b, 2a, 3a, 4a,
5a genotypes were downloaded for subsequent analysis.
Accession numbers are: [GenBank:D10749, Gen-
Bank:AF011751] (genotype 1a); [GenBank:AB016785,
GenBank:AB049087] (genotype 1b); [Gen-
Bank:AB047639, GenBank:AF169002] (genotype 2a);
[GenBank:AF046866, GenBank:D17763] (genotype 3a);
[GenBank:Y11604, GenBank:D45193] (genotype 4a);
[GenBank:AF064490, GenBank:Y13184] (genotype 5a).
Sequence homology analysis
The sequences were pairwise compared and their
sequence homology was scored by means of ClustalW
algorithm (BioEdit software). The between-genotype
homology matrices relative to the fusion peptide (FP), the
C-terminal domain (CT), and the Core fragment (Core),
were then in turn pairwise compared by means of the
Pearson correlation coefficient (r). The scoring of an ele-
vated Pearson correlation between the homology matrices
relative to two different peptides is widely recognized to
be a signature of their functional and physical interaction
[21].
Recurrence Quantification Analysis
In order to complement the co-evolution approach and to
derive a further proof of our hypothesis, we applied a
Recurrence Quantification Analysis (RQA) on selected
sequences by means of their Kyte-Doolitle hydrophobic-
ity profile. This procedure is independent on protein
homology and allows direct comparison of the two inter-
acting proteins for the presence of common hydrophobic-
ity patterns [30,32]. On this basis, the analyzed fragments
were retrieved from one sequence per each genotype of
the dataset. Sequence accession numbers were [Gen-
Bank:AF011751, GenBank:AB016785, Gen-
Bank:AB047639, GenBank:AF046866, GenBank:Y11604,
GenBank:Y13184] for genotype 1a, 1b, 2a, 3a, 4a, 5a,
respectively.BMC Structural Biology 2009, 9:48 http://www.biomedcentral.com/1472-6807/9/48
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Basically the protein sequence is considered as an ordered
series of numbers whose elements are the values of Kyte-
Doolitle hydrophobicity of the residues along the
sequence. In the case of cross-recurrence mode, two differ-
ent sequences A and B are compared as for all the possible
(a,b) ordered pairs of residues, whenever the i-th residue
of protein A has a very similar hydrophobicity with resi-
due j-th of protein B, a pixel is darkened in the matrix hav-
ing as rows and columns the different residues of protein
A and B respectively.
We used two numerical descriptors of cross-recurrence,
the percentage of recurrent pairs, called REC (pairs of res-
idues having very similar hydrophobicity in the two
sequences/total number of distinct pairs) and the percent-
age of "deterministic recurrences", called DET (contigu-
ous recurrent pairs/total recurrent pairs). The threshold
for two i and j residues to be considered as very similar in
hydrophobicity and consequently the ij pair to be recur-
rent was set to 5% of mean distance between residues (i.e.
two residues are considered as recurrent if their difference
in hydrophobicity is less than the 5% of mean distance in
hydrophobicity across all the considered pairs). The above
rules allow for the computation of all the amount of cross-
recurrence (both as REC and DET) for all the possible pep-
tide pairs. Where indicated we also used RQA descriptor
called laminarity (LAM) that corresponds to the percent-
age of vertical (horizontal) recurrent lines in the cross
recurrence plot [23].
Abbreviations
HCV: Hepatitis C Virus; FP: Fusion Peptide; TM: Trans-
membrane; CT: C-terminal; IT: Intervening tract; RQA:
Recurrence Quantification Analysis; TBE: Tick Borne
Encephalitis Virus; DET: percentage of deterministic recur-
rences; REC: percentage of recurrent pairs; LAM: laminar-
ity i.e. percentage of recurrent lines in the cross recurrence
plot.
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